Business / Economy Sep 8, 2020
Hedge funds say no turning back on Abe’s Japan reforms
Despite a change in leader later this month, it has been suggested that Japan Inc. will continue down its current path.
Despite a change in leader later this month, it has been suggested that Japan Inc. will continue down its current path.
Long-haulers — survivors of COVID-19 left with debilitating conditions — represent another insidious dimension of the pandemic.
Japan risks becoming a warning for what happens when a country moves too fast to normalize its economy and doesn’t adjust its strategy when the outbreak changes.
Experts contend that the existence of public health centers are one of the key reasons Japan was able to avoid an explosion in coronavirus cases.
Measures to control the virus have melted away social norms like putting on makeup in the morning or spritzing on perfume before a night out.
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled. The final results of the trial for ...
A growing number of worrying reports have shown patients appearing to have a reactivation of symptoms, testing positive again, or even potentially being reinfected.
Now that the government is urging consumers and businesses to step up efforts to contain the coronavirus outbreak, shoppers may finally have no excuse but to embrace e-commerce and wean themselves from brick-and-mortar stores. Prime Minister Shinzo Abe declared a state of emergency for Tokyo ...
The spreading coronavirus has health officials from the U.S. to Europe searching for answers. To find them, they could look to the experience of Asia, which has been battling the deadly pathogen since January — with some success. In a little over two months, the ...
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said. "The world has to be more proactive than reactive," Christophe Weber, CEO of Takeda Pharmaceutical Co., said in an interview. Although ...